Behçet's disease natural history, complications and prognosis: Difference between revisions

Jump to navigation Jump to search
m (Bot: Removing from Primary care)
 
(11 intermediate revisions by 2 users not shown)
Line 1: Line 1:
__NOTOC__
__NOTOC__
{{Behçet's disease}}
{{Behçet's disease}}
{{CMG}}
{{CMG}}; {{AE}} {{HQ}}


==Overview==
==Overview==
If left untreated, [#]% of patients with [disease name] may progress to develop [manifestation 1], [manifestation 2], and [manifestation 3].
The symptoms of Behçet disease usually develop in the second to third decade of life, and start with symptoms such as [[uveitis]], [[mouth]] sores, and [[Skin lesion|skin lesions]]. Common complications of Behçet disease include neuro Behçet, [[vision loss]], and [[aneurysm]]. Depending on the extent of the disease at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as good. The worst prognoses are associated with [[retinal]] [[vasculitis]], leading to [[blindness]]; [[vascular]] [[aneurysm]] formation, with possible rupture; and neuro–Behçet syndrome, which may lead to [[dementia]] despite appropriate aggressive treatment.


OR
Common complications of [disease name] include [complication 1], [complication 2], and [complication 3].
OR
Prognosis is generally excellent/good/poor, and the 1/5/10-year mortality/survival rate of patients with [disease name] is approximately [#]%.
==Natural History, Complications, and Prognosis==
==Natural History, Complications, and Prognosis==


===Natural History===
===Natural History===
*The symptoms of Behcet disease usually develop in the second to third decade of life, and start with symptoms such as vision problems, arthritis, and .  
*The symptoms of Behçet disease usually develop in the second to third decade of life, and start with [[Symptom|symptoms]] such as [[uveitis]], mouth sores, and [[Skin lesion|skin lesions]].<ref name="pmid10528040">{{cite journal| author=Sakane T, Takeno M, Suzuki N, Inaba G| title=Behçet's disease. | journal=N Engl J Med | year= 1999 | volume= 341 | issue= 17 | pages= 1284-91 | pmid=10528040 | doi=10.1056/NEJM199910213411707 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10528040  }} </ref>
*The symptoms of (disease name) typically develop ___ years after exposure to ___.


===Complications===
===Complications===
*Common complications of Behcet disease include:
*Common complications of Behçet disease include:<ref name="pmid14727454">{{cite journal| author=Zouboulis CC, Vaiopoulos G, Marcomichelakis N, Palimeris G, Markidou I, Thouas B et al.| title=Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behçet's disease in Greece. | journal=Clin Exp Rheumatol | year= 2003 | volume= 21 | issue= 4 Suppl 30 | pages= S19-26 | pmid=14727454 | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=14727454  }} </ref>
**Neuro Behcet
**Neuro Behçet
**Vision loss
**[[Vision loss]]
**Aneurysm
**[[Aneurysm]]


===Prognosis===
===Prognosis===
*Depending on the extent of the disease at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as good.
*Depending on the extent of the disease at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as good.<ref name="pmid27475793">{{cite journal| author=Sota J, Vitale A, Orlando I, Lopalco G, Franceschini R, Fabiani C et al.| title=Auditory involvement in Behcet's disease: relationship with demographic, clinical, and therapeutic characteristics. | journal=Clin Rheumatol | year= 2017 | volume= 36 | issue= 2 | pages= 445-449 | pmid=27475793 | doi=10.1007/s10067-016-3367-x | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=27475793  }} </ref>
*The worst prognoses are associated with retinal vasculitis, leading to blindness; vascular aneurysm formation, with possible rupture; and neuro–Behçet syndrome, which may lead to dementia despite appropriate aggressive treatment.
*The worst prognoses are associated with [[retinal]] [[vasculitis]], leading to [[blindness]]; [[vascular]] [[aneurysm]] formation, with possible rupture; and neuro–Behçet syndrome, which may lead to [[dementia]] despite appropriate aggressive treatment.


==References==
==References==
Line 33: Line 25:
{{WH}}
{{WH}}
{{WS}}
{{WS}}
[[Category:Autoimmune diseases]]
 
[[Category:Medicine]]
[[Category:Up-To-date]]
[[Category:Dermatology]]
[[Category:Dermatology]]
[[Category:Rheumatology]]
[[Category:Rheumatology]]

Latest revision as of 20:36, 29 July 2020

Behçet's disease Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Behçet's disease from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Behçet's disease natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Behçet's disease natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Behçet's disease natural history, complications and prognosis

CDC on Behçet's disease natural history, complications and prognosis

Behçet's disease natural history, complications and prognosis in the news

Blogs on Behçet's disease natural history, complications and prognosis</smal

Directions to Hospitals Treating Behçet's disease

Risk calculators and risk factors for Behçet's disease natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Hamid Qazi, MD, BSc [2]

Overview

The symptoms of Behçet disease usually develop in the second to third decade of life, and start with symptoms such as uveitis, mouth sores, and skin lesions. Common complications of Behçet disease include neuro Behçet, vision loss, and aneurysm. Depending on the extent of the disease at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as good. The worst prognoses are associated with retinal vasculitis, leading to blindness; vascular aneurysm formation, with possible rupture; and neuro–Behçet syndrome, which may lead to dementia despite appropriate aggressive treatment.

Natural History, Complications, and Prognosis

Natural History

  • The symptoms of Behçet disease usually develop in the second to third decade of life, and start with symptoms such as uveitis, mouth sores, and skin lesions.[1]

Complications

Prognosis

  • Depending on the extent of the disease at the time of diagnosis, the prognosis may vary. However, the prognosis is generally regarded as good.[3]
  • The worst prognoses are associated with retinal vasculitis, leading to blindness; vascular aneurysm formation, with possible rupture; and neuro–Behçet syndrome, which may lead to dementia despite appropriate aggressive treatment.

References

  1. Sakane T, Takeno M, Suzuki N, Inaba G (1999). "Behçet's disease". N Engl J Med. 341 (17): 1284–91. doi:10.1056/NEJM199910213411707. PMID 10528040.
  2. Zouboulis CC, Vaiopoulos G, Marcomichelakis N, Palimeris G, Markidou I, Thouas B; et al. (2003). "Onset signs, clinical course, prognosis, treatment and outcome of adult patients with Adamantiades-Behçet's disease in Greece". Clin Exp Rheumatol. 21 (4 Suppl 30): S19–26. PMID 14727454.
  3. Sota J, Vitale A, Orlando I, Lopalco G, Franceschini R, Fabiani C; et al. (2017). "Auditory involvement in Behcet's disease: relationship with demographic, clinical, and therapeutic characteristics". Clin Rheumatol. 36 (2): 445–449. doi:10.1007/s10067-016-3367-x. PMID 27475793.

Template:WH Template:WS